#ocrelizumab
Live, measured metrics for the hashtag #ocrelizumab from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.
Own #ocrelizumab
This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.
Day-by-day usage
measured · mas.to (Mastodon public tags API) · fetched 2026-10-09 09:03 UTC0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.
Related hashtags
measured · mas.to (Mastodon public search API) · fetched 2026-10-09 09:03 UTCNo related tags with measured usage found for #ocrelizumab.
Live pulse
measured · mas.to (Mastodon tag timeline) · fetched 2026-10-09 09:03 UTCEverything below is measured over the latest 16 public posts (spanning ~33080 hours).
Posting hours (UTC) — busiest: 15:00
Languages: German (9) · English (6) · Spanish (1)
Avg boosts / post: 0.3
Top of the latest posts
https://www.europesays.com/ch/126018/ Roche gets Phase 3 trial waiver for higher dose of multiple sclerosis drug | Industry News #CDSCO #MSDrug #MultipleSclerosis #NeurologyDrugs #ocrelizumab #Ocrevus #Phase3TrialWaiver #Phase4ClinicalTrial
https://www.europesays.com/ch/125936/ Roche gets Phase 3 trial waiver for higher dose of multiple sclerosis drug | Industry News #CDSCO #MSDrug #MultipleSclerosis #NeurologyDrugs #ocrelizumab #Ocrevus #Phase3TrialWaiver #Phase4ClinicalTrial
https://www.europesays.com/at/326703/ Wie Darmbakterien die Wirkung von Krebstherapien verdoppeln können #AI #ARTIFICIALINTELLIGENCE #AT #Austria #Autoimmunität #Biomarker #Cd8TZellen #Chemotherapie #Darmbakterien #Gallensaeuren #Gesundheit
What “ocrelizumab” means
WikipediaOcrelizumab, sold under the brand name Ocrevus, is a medication used for the treatment of multiple sclerosis. It is a humanized anti-CD20 monoclonal antibody. It targets CD20 marker on B lymphocytes and is an immunosuppressive drug. Ocrelizumab binds to an epitope that overlaps with the epitope to which rituximab binds. It is administered by intravenous infusion. The fixed-dose combination ocrelizumab/hyaluronidase is administered by subcutaneous injection.
“Ocrelizumab” on Wikipedia (CC BY-SA) →#ocrelizumab across platforms
every network with a public tag surfaceFollow #ocrelizumab straight to each platform’s own tag page. Where a platform publishes open data we measure it above; the rest lock their numbers behind paid APIs, so we link rather than guess.
Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/ocrelizumab